1. Главная
  2. Ресурсы
  3. Библиотечный поиск
AllostericConversation in theAndrogen ReceptorLigand-Binding DomainSurfaces Solène GrosdidierLaia R. CarbóVíctor Buzón2012 год

Allosteric Conversation in the Androgen Receptor Ligand-Binding Domain Surfaces
статья из журнала

Полный текстСтраница публикацииПубликация в OpenAlex
Аннотация: Androgen receptor (AR) is a major therapeutic target that plays pivotal roles in prostate cancer (PCa) and androgen insensitivity syndromes. We previously proposed that compounds recruited to ligand-binding domain (LBD) surfaces could regulate AR activity in hormone-refractory PCa and discovered several surface modulators of AR function. Surprisingly, the most effective compounds bound preferentially to a surface of unknown function [binding function 3 (BF-3)] instead of the coactivator-binding site [activation function 2 (AF-2)]. Different BF-3 mutations have been identified in PCa or androgen insensitivity syndrome patients, and they can strongly affect AR activity. Further, comparison of AR x-ray structures with and without bound ligands at BF-3 and AF-2 showed structural coupling between both pockets. Here, we combine experimental evidence and molecular dynamic simulations to investigate whether BF-3 mutations affect AR LBD function and dynamics possibly via allosteric conversation between surface sites. Our data indicate that AF-2 conformation is indeed closely coupled to BF-3 and provide mechanistic proof of their structural interconnection. BF-3 mutations may function as allosteric elicitors, probably shifting the AR LBD conformational ensemble toward conformations that alter AF-2 propensity to reorganize into subpockets that accommodate N-terminal domain and coactivator peptides. The induced conformation may result in either increased or decreased AR activity. Activating BF-3 mutations also favor the formation of another pocket (BF-4) in the vicinity of AF-2 and BF-3, which we also previously identified as a hot spot for a small compound. We discuss the possibility that BF-3 may be a protein-docking site that binds to the N-terminal domain and corepressors. AR surface sites are attractive pharmacological targets to develop allosteric modulators that might be alternative lead compounds for drug design.
Год издания: 2012
Авторы: Solène Grosdidier, Laia R. Carbó, Víctor Buzón, Greg N. Brooke, Phuong Nguyen, John D. Baxter, Charlotte L. Bevan, Paul Webb, Eva Estébanez‐Perpiñá, Juan Fernández‐Recio
Издательство: Oxford University Press
Источник: Molecular Endocrinology
Ключевые слова: Hormonal and reproductive studies, Estrogen and related hormone effects, Mass Spectrometry Techniques and Applications
Другие ссылки: Molecular Endocrinology (HTML)
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (PDF)
Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (HTML)
Europe PMC (PubMed Central) (HTML)
PubMed Central (HTML)
Open Access at Essex (University of Essex) (HTML)
Open Access at Essex (University of Essex) (HTML)
PubMed (HTML)